Latest News

  • Alkermes plc Reports Third Quarter 2014 Financial Results Read More
  • Alkermes to Host Conference Call to Discuss Third Quarter 2014 Financial Results Read More
  • Alkermes’ New Drug Application for Aripiprazole Lauroxil for Treatment of Schizophrenia Accepted for Filing by U.S. FDA Read More

Investors

Learn More

Working at Alkermes

Join Our Team